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EDITORIAL COMMENTS
It is exciting to see new treatment options in the
male incontinence space. Our solutions at present
are imperfect, often leaving men with continued
leakage or the need for future surgery.1 The authors
describe their multi-institutional experience using
the ATOMS for male stress incontinence. Similar to
men we see in clinic, the cohort had high rates of
radiation, bladder neck contracture and previous
incontinence surgery.
While followup is short (median 9 months),
complication rates were acceptable (22.3% overall
and 4.4% for Clavien III). Satisfaction was measured
with a global, binary question in the physician office
and, while relatively high overall, it likely missed
some aspects of the patient experience. As with
everything in reconstructive urology, irradiated pa-
tients did worse. They were less dry and had lower
satisfaction scores.
With an acceptable complication rate, the idea
that a sling outcome can be improved by adding
fluid in the office is attractive. The technical de-
mands of ATOMS placement will be familiar to
those who already place slings or do male ure-
thral surgery. It remains unknown how durable
the results will be or if cuff erosion, not seen
in the short term, will develop with longer
followup.
There will hopefully be a day in our lifetimes
where our incontinence treatments are not
needed. Maybe the therapies that lead to leakage
are refined or no longer used. The holy grail of
incontinence management would be devoid of
implanting a foreign body or requiring the patient
to squeeze a pump. Perhaps the voluntary rhab-
dosphincter is regenerated with energy, stem
cells or tissue grown in the laboratory. Until then,
as the authors have done, we must try to develop
and test new technologies to help men with
incontinence.
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The third generation ATOMS device used in this
trial has a silicon, fully precovered scrotal port sys-
tem.1 Post-procedure overall continence was 80%
(0 or 1 pad per day) and 70% of patients needed
pressure adjustment of the saline through the scrotal
port a mean of 2.4 times. This is the advantage and
the differentiating factor of the ATOMS device,
although most complications were also related to this
feature. Seven of the 160 patients had Clavien 3
complications requiring intervention, which were
related to the injection port.
It is important to identify the subset of patient
who will derive maximum benefit from the
ATOMS device. In general, the nonadjustable
male slings do not work well for moderate to
severe incontinence but remain an alternative for
mild stress leakage. The artificial urinary
sphincter remains the gold standard. Tested for
several generations and more than 30 years, it is
offers reliable results for all grades of inconti-
nence. The long-term results of the latest ATOMS
device are still awaited. The European multi-
center trial of ATOMS evaluated 287 men with a
median followup of 31 months fully. It included all
3 generations and the current silicon covered
scrotal port system had a median followup of only 6
months. There was an overall explantation rate of
20%, the most common cause being titanium
intolerance. The current study had only a single
case of explantation following infection. It is
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